Sabrina Forveille

903 total citations
18 papers, 597 citations indexed

About

Sabrina Forveille is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Sabrina Forveille has authored 18 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Sabrina Forveille's work include Autophagy in Disease and Therapy (7 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (4 papers). Sabrina Forveille is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (4 papers). Sabrina Forveille collaborates with scholars based in France, Sweden and China. Sabrina Forveille's co-authors include Guido Kroemer, Oliver Kepp, Allan Sauvat, Peng Liu, Laurence Zitvogel, Lucillia Bezu, Laura Senovilla, Liwei Zhao, Heng Zhou and Kristina Iribarren and has published in prestigious journals such as Nucleic Acids Research, Methods in enzymology on CD-ROM/Methods in enzymology and Cell Death and Differentiation.

In The Last Decade

Sabrina Forveille

18 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabrina Forveille France 11 268 264 197 105 64 18 597
Sofie Van Eygen Belgium 6 275 1.0× 115 0.4× 82 0.4× 134 1.3× 6 0.1× 6 499
Omar I. Vivar United States 9 218 0.8× 164 0.6× 85 0.4× 26 0.2× 5 0.1× 19 514
Jingfeng Zhou China 13 411 1.5× 76 0.3× 129 0.7× 25 0.2× 16 0.3× 22 609
Kay Hänggi United States 10 498 1.9× 355 1.3× 265 1.3× 55 0.5× 5 0.1× 16 839
Mélanie Beaujouin France 7 320 1.2× 63 0.2× 107 0.5× 53 0.5× 11 0.2× 8 569
Rahul Kumar Vempati India 8 424 1.6× 143 0.5× 247 1.3× 38 0.4× 5 0.1× 12 699
Se Jin Oh South Korea 15 359 1.3× 162 0.6× 190 1.0× 38 0.4× 3 0.0× 22 601
Karen Coffman United States 12 533 2.0× 118 0.4× 314 1.6× 29 0.3× 7 0.1× 15 970
Katherine Sully United Kingdom 9 267 1.0× 104 0.4× 141 0.7× 98 0.9× 4 0.1× 10 542
Marie‐Line Puiffe France 9 236 0.9× 106 0.4× 140 0.7× 12 0.1× 9 0.1× 10 470

Countries citing papers authored by Sabrina Forveille

Since Specialization
Citations

This map shows the geographic impact of Sabrina Forveille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Forveille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Forveille more than expected).

Fields of papers citing papers by Sabrina Forveille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Forveille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Forveille. The network helps show where Sabrina Forveille may publish in the future.

Co-authorship network of co-authors of Sabrina Forveille

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Forveille. A scholar is included among the top collaborators of Sabrina Forveille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Forveille. Sabrina Forveille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Forveille, Sabrina, Liwei Zhao, Allan Sauvat, et al.. (2025). Patritumab deruxtecan induces immunogenic cell death. OncoImmunology. 14(1). 2514050–2514050. 4 indexed citations
2.
Forveille, Sabrina, et al.. (2025). Datopotamab deruxtecan induces hallmarks of immunogenic cell death. PubMed. 9. 194–200. 2 indexed citations
3.
Sauvat, Allan, Marion Leduc, Gautier Stoll, et al.. (2024). Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death. Autophagy. 21(5). 934–956. 5 indexed citations
4.
Cerrato, Giulia, Allan Sauvat, Yanhua Hu, et al.. (2023). 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis. Cell Death and Disease. 14(11). 758–758. 2 indexed citations
5.
Forveille, Sabrina, Allan Sauvat, Shuai Zhang, et al.. (2022). Assessment of type I interferon responses as a feature of immunogenic cell death. Methods in cell biology. 172. 135–143. 4 indexed citations
6.
Forveille, Sabrina, Marion Leduc, Allan Sauvat, et al.. (2021). High throughput screening for autophagy. Methods in cell biology. 165. 89–101. 1 indexed citations
7.
Wu, Qi, Ai-Ling Tian, Bei Li, et al.. (2021). IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms. Journal for ImmunoTherapy of Cancer. 9(6). e002722–e002722. 65 indexed citations
8.
Kepp, Oliver, Allan Sauvat, Marion Leduc, et al.. (2019). A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers. OncoImmunology. 8(8). 1606665–1606665. 14 indexed citations
9.
Forveille, Sabrina, Juliette Humeau, Allan Sauvat, et al.. (2019). Quinacrine-mediated detection of intracellular ATP. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 103–113. 11 indexed citations
10.
Xie, Wei, Sabrina Forveille, Kristina Iribarren, et al.. (2019). Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity. OncoImmunology. 8(11). e1656502–e1656502. 56 indexed citations
11.
Zhou, Heng, Laura Mondragón, Wei Xie, et al.. (2018). Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death and Disease. 9(11). 1086–1086. 17 indexed citations
12.
Bezu, Lucillia, Allan Sauvat, Juliette Humeau, et al.. (2018). eIF2α phosphorylation is pathognomonic for immunogenic cell death. Cell Death and Differentiation. 25(8). 1375–1393. 185 indexed citations
13.
Zhou, Heng, Sabrina Forveille, Allan Sauvat, et al.. (2016). The oncolytic peptide LTX-315 triggers immunogenic cell death. Cell Death and Disease. 7(3). e2134–e2134. 99 indexed citations
14.
Sauvat, Allan, Huimin Zhou, Marion Leduc, et al.. (2016). Automated Analysis of Fluorescence Colocalization. Methods in enzymology on CD-ROM/Methods in enzymology. 588. 219–230. 3 indexed citations
15.
Zhou, Heng, Allan Sauvat, Lígia C. Gomes‐da‐Silva, et al.. (2016). The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. 23(12). 2031–2041. 28 indexed citations
16.
Hubé, Florent, Damien Ulveling, Alain Sureau, Sabrina Forveille, & Claire Francastel. (2016). Short intron-derived ncRNAs. Nucleic Acids Research. 45(8). gkw1341–gkw1341. 23 indexed citations
17.
Forveille, Sabrina, Heng Zhou, Allan Sauvat, et al.. (2015). The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle. 14(21). 3506–3512. 33 indexed citations
18.
Zhou, Heng, Sabrina Forveille, Allan Sauvat, et al.. (2015). The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. Oncotarget. 6(29). 26599–26614. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026